Transforming Liver Cancer Care

Early detection for better treatment outcomes – MoleculeDx leads the way.

Get Screened Now

Comprehensive Screening Services

State-of-the-art tools for early cancer detection

Unhappy patient with headache and closed eyes

Fusion HCC Predictor

Prognostic tools to optimize liver transplant success rates and outcomes.

Transplant Predictors (coming soon)

Prognostic tools to optimize liver transplant success rates and outcomes.

Our Story

With over a decade of industry experience, MoleculeDx leads the way in transforming cancer detection and risk assessment. Specializing in early-stage liver cancer diagnosis, our innovative technology sets new standards in healthcare.

Learn More

Many liver cancer patients have normal AFP levels. There are no real markers for HCC screening, and serum AFP accuracy is around 50-60%

JEFFREY S. CRIPPINProfessor of Medicine, Director of Liver Disease, Wash U Barnes Hospital

Our Unique Value Proposition

MoleculeDx delivers advanced screening tools for early cancer detection, improving patient outcomes and survival rates.

Precision Diagnosis

Accurate and early identification of liver cancers for improved treatment options.

Learn More

Advanced Technology

Innovative serum fusion transcript-based machine-learning technology for reliable predictions.

Learn More

Join the Fight Against Liver Cancer

Take a step towards early detection and better outcomes. Schedule your screening now.

Get Screened Now